牙周炎与肠道菌群相关性研究进展

doi:10.13591/j.cnki.kqyx.2022.11.017

摘要/Abstract

摘要： 越来越多的研究表明牙周炎和肠道菌群之间关系密切。牙周炎的患者能够通过吞咽将口腔细菌转移到肠道定植,肠道原生菌群被改变,进而引发一系列肠道黏膜的免疫反应。肠道菌群失调又会导致一系列全身系统疾病,其中代表性的疾病就是炎症性肠病炎症性肠病(inflammatory bowel disease,IBD)。本文以IBD为切入点就牙周炎影响肠道菌群的可能途径以及炎症进展时、炎症得到控制后肠道菌群的变化进行综述。

关键词: 牙周炎, 口腔细菌, 肠道菌群, 炎症性肠病

Abstract: A growing number of studies suggest a close relationship between periodontitis and the intestinal flora. Oral bacteria swallowed by patients with chronic periodontitis could be transferred to intestinal colonization, and the primary intestinal flora is altered, thereby triggering a series of immune responses in the intestinal mucosa. Intestinal flora imbalance will lead to a series of systemic diseases, of which the representative disease is inflammatory bowel disease(IBD). Based on IBD, this article reviews the possible ways of periodontitis affecting intestinal flora and changes of intestinal flora during the progress of inflammation and after inflammation is controlled.

Key words: periodontitis, oral bacteria, intestinal flora, inflammatory bowel disease

中图分类号:

R783.1

谢雨桐, 胡颖哲, 高鹏玉, 徐全臣. 牙周炎与肠道菌群相关性研究进展[J]. 口腔医学, 2022, 42(11): 1047-1051.

XIE Yutong, HU Yingzhe, GAO Pengyu, XU Quanchen. Progress of research on the correlation between chronic periodontitis and intestinal flora[J]. Stomatology, 2022, 42(11): 1047-1051.

参考文献

[1] Park SY, Hwang BO, Lim M, et al. Oral-gut microbiome axis in gastrointestinal disease and cancer[J]. Cancers, 2021, 13(9):2124.
[2] Hoare A, Soto C, Rojas-Celis V, et al. Chronic inflammation as a link between periodontitis and carcinogenesis[J]. Mediators Inflamm, 2019, 2019:1029857.
[3] Kitamoto S, Nagao-Kitamoto H, Hein R, et al. The bacterial connection between the oral cavity and the gut diseases[J]. J Dent Res, 2020, 99(9):1021-1029.
[4] de Mello-Neto JM, Nunes JGR, Tadakamadla SK, et al. Immunological traits of patients with coexistent inflammatory bowel disease and periodontal disease:A systematic review[J]. Int J Environ Res Public Health, 2021, 18(17):8958.
[5] Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease[J]. J Med Life, 2019, 12(2):113-122.
[6] Muhvić-Urek M, Tomac-Stojmenović M, Mijandrušić-Sinčić B. Oral pathology in inflammatory bowel disease[J]. World J Gastroenterol, 2016, 22(25):5655-5667.
[7] Agossa K, Roman L, Gosset M, et al. Periodontal and dental health in inflammatory bowel diseases:A systematic review[J]. Expert Rev Gastroenterol Hepatol, 2021:2021Jul19;1-2021Jul1915.
[8] Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project[J]. Nature, 2007, 449(7164):804-810.
[9] Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease[J]. Gut, 2004, 53(1):1-4.
[10] Koutsochristou V, Zellos A, Dimakou K, et al. Dental caries and periodontal disease in children and adolescents with inflammatory bowel disease:A case-control study[J]. Inflamm Bowel Dis, 2015, 21(8):1839-1846.
[11] Strauss J, Kaplan GG, Beck PL, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J]. Inflamm Bowel Dis, 2011, 17(9):1971-1978.
[12] Figueredo CM, Martins AP, Lira-Junior R, et al. Activity of inflammatory bowel disease influences the expression of cytokines in gingival tissue[J]. Cytokine, 2017, 95:1-6.
[13] Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities[J]. Nat Rev Immunol, 2021, 21(7):426-440.
[14] Wang F, Guan M, Wei LT, et al. IL-18 promotes the secretion of matrix metalloproteinases in human periodontal ligament fibroblasts by activating NF-κB signaling[J]. Mol Med Rep, 2019, 19(1):703-710.
[15] Nair V, Bandyopadhyay P, Kundu D, et al. Estimation of interleukin-18 in the gingival crevicular fluid and serum of Bengali population with periodontal health and disease[J]. J Indian Soc Periodontol, 2016, 20(3):260-264.
[16] Koliarakis I, Messaritakis I, Nikolouzakis TK, et al. Oral bacteria and intestinal dysbiosis in colorectal cancer[J]. Int J Mol Sci, 2019, 20(17):4146.
[17] Lourenşo TGB, Spencer SJ, Alm EJ, et al. Defining the gut microbiota in individuals with periodontal diseases:An exploratory study[J]. J Oral Microbiol, 2018, 10(1):1487741.
[18] Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota[J]. Sci Rep, 2014, 4:4828.
[19] Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement[J]. Cell Host Microbe, 2011, 10(5):497-506.
[20] Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver[J]. PloS one, 2015, 10(7):e0134234.
[21] Huang YZ, Liao Y, Luo BY, et al. Non-surgical periodontal treatment restored the gut microbiota and intestinal barrier in apolipoprotein E^-/- mice with periodontitis[J]. Front Cell Infect Microbiol, 2020, 10:498.
[22] Jia LM, Tu Y, Jia XY, et al. Probiotics ameliorate alveolar bone loss by regulating gut microbiota[J]. Cell Prolif, 2021, 54(7):e13075.
[23] Pacifici R. Bone remodeling and the microbiome[J]. Cold Spring Harb Perspect Med, 2018, 8(4):a031203.
[24] Yang LC, Lin SW, Li IC, et al. Lactobacillus plantarum GKM3 and Lactobacillus paracasei GKS₆ supplementation ameliorates bone loss in ovariectomized mice by promoting osteoblast differentiation and inhibiting osteoclast formation[J]. Nutrients, 2020, 12(7):1914.
[25] Sudhakara P, Gupta A, Bhardwaj A, et al. Oral dysbiotic communities and their implications in systemic diseases[J]. Dent J (Basel), 2018, 6(2):10.
[26] Takiishi T, Fenero CIM, Câmara NOS. Intestinal barrier and gut microbiota:Shaping our immune responses throughout life[J]. Tissue Barriers, 2017, 5(4):e1373208.
[27] Sato K, Takahashi N, Kato T, et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system[J]. Sci Rep, 2017, 7(1):6955.
[28] Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome[J]. Gut, 2016, 65(5):740-748.
[29] Sohn J, Sun YJ, Genco RJ, et al. The periodontal microenvironment:A potential reservoir for intestinal pathobionts in Crohn's disease[J]. Curr Oral Heal Rep, 2020, 7(1):37-44.
[30] Liu YM, Huang WX, Wang JQ, et al. Multifaceted impacts of periodontal pathogens in disorders of the intestinal barrier[J]. Front Immunol, 2021, 12:693479.
[31] Walker MY, Pratap S, Southerland JH, et al. Role of oral and gut microbiome in nitric oxide-mediated colon motility[J]. Nitric Oxide, 2018, 73:81-88.
[32] 林淑岚, 赵蕾. 炎症性肠病对牙周病影响的研究进展[J]. 口腔医学研究, 2021, 37(6):497-500.
[33] Hajishengallis G. Periodontitis:from microbial immune subversion to systemic inflammation[J]. Nat Rev Immunol, 2015, 15(1):30-44.
[34] Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis[J]. JCI Insight, 2017, 2(19):e94416.
[35] Velsko IM, Chukkapalli SS, Rivera-Kweh MF, et al. Fusobacterium nucleatum alters atherosclerosis risk factors and enhances inflammatory markers with an atheroprotective immune response in ApoE(null) mice[J]. PLoS One, 2015, 10(6):e0129795.
[36] Tsukasaki M, Komatsu N, Nagashima K, et al. Host defense against oral microbiota by bone-damaging T cells[J]. Nat Commun, 2018, 9(1):701.
[37] Horliana ACRT, Chambrone L, Foz AM, et al. Dissemination of periodontal pathogens in the bloodstream after periodontal procedures:A systematic review[J]. PLoS One, 2014, 9(5):e98271.
[38] Kojima A, Nakano K, Wada K, et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis[J]. Sci Rep, 2012, 2:332.
[39] Bunte K, Beikler T. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases[J]. Int J Mol Sci, 2019, 20(14):3394.
[40] Li XX, Bechara R, Zhao JJ, et al. IL-17 receptor-based signaling and implications for disease[J]. Nat Immunol, 2019, 20(12):1594-1602.
[41] Kitamoto S, Nagao-Kitamoto H, Jiao YZ, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis[J]. Cell, 2020, 182(2):447-462.e14.
[42] Gaffen SL, Moutsopoulos NM. Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity[J]. Sci Immunol, 2020, 5(43):eaau4594.
[43] Dutzan N, Kajikawa T, Abusleme L, et al. A dysbiotic microbiome triggers T H₁₇ cells to mediate oral mucosal immunopathology in mice and humans[J]. Sci Transl Med, 2018, 10(463):eaat0797.
[44] Beura LK, Hamilton SE, Bi K, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice[J]. Nature, 2016, 532(7600):512-516.
[45] Graves DT, Corrêa JD, Silva TA. The oral microbiota is modified by systemic diseases[J]. J Dent Res, 2019, 98(2):148-156.
[46] Corrêa JD, Calderaro DC, Ferreira GA, et al. Subgingival microbiota dysbiosis in systemic lupus erythematosus:Association with periodontal status[J]. Microbiome, 2017, 5(1):34.
[47] Corrêa JD, Fernandes GR, Calderaro DC, et al. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients[J]. Sci Rep, 2019, 9(1):8379.
[48] Rautava J, Pinnell LJ, Vong L, et al. Oral microbiome composi-tion changes in mouse models of colitis[J]. J Gastroenterol Hepatol, 2015, 30(3):521-527.
[49] Lira-Junior R, Figueredo CM. Periodontal and inflammatory bowel diseases:Is there evidence of complex pathogenic interactions?[J]. World J Gastroenterol, 2016, 22(35):7963-7972.
[50] Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease-epidemiology, genetics, and pathogenesis[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(4):307-317.
[51] Vavricka SR, Rogler G, Gantenbein C, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort[J]. Inflamm Bowel Dis, 2015, 21(8):1794-1800.
[52] Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease[J]. Clin Rev Allergy Immunol, 2012, 42(1):102-111.
[53] Byrd KM, Gulati AS. The “gum-gut” axis in inflammatory bowel diseases:A hypothesis-driven review of associations and advances[J]. Front Immunol, 2021, 12:620124.
[54] Weitzmann MN. Bone and the immune system[J]. Toxicol Pathol, 2017, 45(7):911-924.